-
Pernix Therapeutics Announces Result of Bid Process for Acquisition of Worldwide Rights to Contrave® for Weight Loss
-
Pernix Therapeutics Reports First Quarter 2018 Financial Results
-
Pernix Therapeutics Reports First Quarter 2018 Financial Results
-
Pernix Therapeutics Announces Participation in Lead Bid for Acquisition of Worldwide Rights to Contrave® for Weight Loss
-
Pernix Therapeutics Announces Participation in Lead Bid for Acquisition of Worldwide Rights to Contrave® for Weight Loss
-
Pre-Open Stock Movers 05/02: (PTX) (OPWR) (OREX) (APOL) Higher; (NRX) (BIND) (UPL) (BIDU) Lower (more...)
-
Market Wrap: Wholesale Inventories Gain in Feb.; Allied Nevada Gold Goes Belly-Up; Credit Suisse Dubs New CEO
-
Unusual 11 Mid-Day Movers 03/18: (ULTR) (PRWT) (SPMD) Higher; (AMBO) (PTX) (UTSI) Lower

